Heart Failure

In patients with severe tricuspid regurgitation, transcatheter tricuspid valve replacement plus medical therapy improved outcomes compared with medical therapy alone, researchers reported at TCT 2024.

Childhood BMI, blood pressure and smoking status performed as well as lipid levels in predicting the risk for cardiovascular events in adulthood, according to study findings published in Pediatrics.

SAN DIEGO — Blood volume monitoring may lead to shorter hospital stays and fewer readmissions for adults with end-stage kidney disease and heart failure, data show.

SAN DIEGO — Compared with placebo, finerenone was associated with reductions in albuminuria and decreased risk of new-onset albuminuria among adults with heart failure, according to data from the FINEARTS-HF trial.

BOSTON — Hospitalization for a cardiac cause vs. a noncardiac cause in patients with cystic fibrosis yielded elevated in-hospital mortality, according to a presentation at the CHEST Annual Meeting.

Standing did not improve cardiovascular health when compared with sitting, results from a cohort study published in the International Journal of Epidemiology showed.

Researchers found that patients with a positive SARS-CoV-2 PCR test faced an increased risk for major adverse cardiac events vs. individuals without SARS-CoV-2; this risk was even higher among patients hospitalized for COVID-19.

A new consensus statement from the Heart Failure Society of America outlines how device-based therapies can help certain patients with HF and how HF devices can be integrated into clinical workflow.

Canagliflozin was associated with increased iron utilization and improved hemoglobin levels for adults with type 2 diabetes and chronic kidney disease, according to data published in Nephrology Dialysis Transplantation.

Baroreflex activation therapy plus optimal medical therapy improved quality of life at 2 years in patients with HF with reduced ejection fraction compared with optimal medical therapy alone, researchers reported.